CIPROFOLXACIN
Manufacturer: NuCare Pharmaceutical, Inc.
Score: 141.0
Ciprofloxacin is a fluoroquinolone antibacterial agent used to treat various infections, including skin and skin structure infections, bone and joint infections, and urinary tract infections. It is available in 250 mg and 500 mg strengths and should be taken orally, with or without food. The drug has several important safety considerations, including the risk of tendinitis and tendon rupture, peripheral neuropathy, and central nervous system effects. Ciprofloxacin is contraindicated in patients with a history of hypersensitivity to the drug or other quinolones, and in patients taking tizanidine. The recommended dosage varies depending on the infection being treated, and dose adjustments may be necessary for patients with renal impairment. Special population considerations include use during pregnancy, nursing mothers, pediatric use, and geriatric use.
Fluoroquinolones, including ciprofloxacin, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together, including tendinitis and tendon rupture, peripheral neuropathy, and central nervous system effects.
Dosage adjustments may be necessary for patients with renal impairment.
500-750 mg every 12 hours
Not recommended
500-750 mg every 12 hours
Not recommended
500 mg every 12 hours
Not recommended
500 mg every 12 hours
Not recommended
500 mg every 12 hours
Not recommended
250 mg single dose
Not recommended
500 mg every 12 hours
15 mg/kg every 12 hours
500-750 mg every 12 hours
15 mg/kg every 8-12 hours
500 mg every 12 hours
Not recommended
500-750 mg every 12 hours
Not recommended
250-500 mg every 12 hours
10-20 mg/kg every 12 hours
500 mg every 12 hours
Not recommended